(Press-News.org) https://www.ninds.nih.gov/news-events/press-releases/common-marker-neurological-diseases-may-play-role-healthy-brainsResearchers have discovered that a protein called phosphorylated α-synuclein, which is associated with several neurodegenerative diseases such as Parkinson’s disease and Lewy body dementia, is also involved in the normal processes of how neurons communicate with each other in a healthy brain. The research, published in Neuron, was funded in part by the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health.
Phosphorylation is a process where a phosphate ion is added to a specific amino acid, or building block, of a protein, in this case the protein α-synuclein. This addition can change the shape of that protein, causing it to change its level of activity. Most studies of phosphorylated α-synuclein have studied its role in certain neurological disorders such as Parkinson’s disease and Lewy body dementia, where it builds up in protein clumps called Lewy bodies. These clumps are thought to be toxic to neurons, and one of the prevailing hypotheses is that the phosphorylation of the protein α-synuclein triggers these diseases.
“In most studies to date, the mere presence of α-synuclein phosphorylation is assumed to be a marker for pathology for certain disorders, like Parkinson’s and Lewy Body dementias,” said Beth-Anne Sieber, Ph.D., program director, NINDS. “Recently, there has been considerable interest in developing drugs that prevent α-synuclein phosphorylation as a way of treating these disorders. These findings challenge the current hypotheses about how these disorders may originate in the brain and may give insight into how we might better treat them.”
Previous work by the lab of Subhojit Roy, M.D., Ph.D., professor at the University of California, San Diego, and senior author of the study, suggested that in a healthy brain, the α-synuclein protein tones down excessive neuronal firing to regulate neuronal communication. While exploring this theory, Roy’s group unexpectedly found that phosphorylation was necessary for the normal function of α-synuclein.
Using a molecular modeling strategy to look at the structure of α-synuclein, Roy and his colleagues led by postdoctoral researcher Leonardo Parra-Rivas, Ph.D. discovered that when α-synuclein is phosphorylated, its structure changes in a way that promotes interactions with other proteins in healthy brains. Furthermore, they observed an association between increasing neural activity electrically or chemically and an increase in the amount of phosphorylated α-synuclein in both cultured cells and in mouse brain tissue. This finding suggests there might be a relationship between synaptic activity and α-synuclein phosphorylation.
Additionally, experiments show phosphorylation is necessary for α-synuclein to play its role in assembling a network of proteins that bind up synaptic vesicles—pockets that release chemicals enabling neurons to communicate with one another and other cells—and to slow neuronal activity. Therefore, phosphorylated α-synuclein acts almost as a brake or clutch mechanism to keep activity in certain neuronal circuits in check, suggesting that it might have a role in healthy brains, which had not previously been investigated.
“In hindsight, we hadn’t been looking at synuclein phosphorylation the right way,” said Roy. “Take for instance the circuits in the olfactory bulb, which according to our data has high levels of phosphorylated α-synuclein. The nose never stops smelling, so it needs to be active all the time. One hypothesis is that synuclein phosphorylation may have evolved as a safety mechanism to protect neuronal circuits that need to be hyperactive.”
The constant presence of α-synuclein phosphorylation in certain brain regions might reflect a need for this biochemical state in those areas. Additional studies are needed to understand how relatively low-frequency events in a healthy brain, when accumulated over a lifetime, can trigger the pathological accumulation of α-synuclein into Lewy bodies, leading to Parkinson’s disease and Lewy body dementias. Furthermore, therapies designed to block the phosphorylation of α-synuclein itself may need to consider the unintended adverse consequences of blocking a process that may help keep neurons functional during peak activity periods.
This work was funded by NINDS (NS111978, NS047101), the Farmer Family Foundation, Aligning Science Across Parkinson’s, and the Michael J. Fox Foundation for Parkinson’s Research.
This press release describes a basic research finding. Basic research increases our understanding of human behavior and biology, which is foundational to advancing new and better ways to prevent, diagnose, and treat disease. Science is an unpredictable and incremental process — each research advance builds on past discoveries, often in unexpected ways. Most clinical advances would not be possible without the knowledge of fundamental basic research.
Article:
Parra-Rivas LA et al. Serine-129 phosphorylation of α-synuclein is an activity-dependent trigger for physiologic protein-protein interactions and synaptic function. Neuron. December 20, 2023. DOI: 10.1016/j.neuron.2023.11.020
###
NINDS is the nation’s leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases.
END
ITHACA, N.Y. – Ask ChatGPT to find a well-known poem and it will probably regurgitate the entire text verbatim – regardless of copyright law – according to a new study by Cornell University researchers.
The study showed that ChatGPT was capable of “memorizing” poems, especially famous ones commonly found online. The findings pose ethical questions about how ChatGPT and other proprietary artificial intelligence models are trained – likely using data scraped from the internet, researchers said.
“It’s generally not good for large language models to memorize large chunks of text, in part because it’s a privacy concern,” ...
Despite the fact that people with sickle cell disease have a much higher risk of serious illness or death if they develop COVID-19, a new study shows they’re also much less likely than those without sickle cell disease to have gotten vaccinated against coronavirus.
Completion of the initial COVID-19 vaccination series was nearly two times lower for adults with sickle cell disease as others their age, the analysis of data in Michigan shows.
In in teens and children over 5, who overall have lower rates of COVID-19 vaccination, those with sickle cell disease were far less likely than other young people to have gotten their doses by summer 2022, the analysis ...
The Brookline Housing Authority (BHA) has partnered with Hebrew SeniorLife, New England’s largest nonprofit provider of senior health care and living communities, and the only senior care organization affiliated with Harvard Medical School, to provide community life services including resident services, fitness, social programming, and nursing in BHA’s senior housing sites.
Hebrew SeniorLife brings to the BHA its model of housing with services called the Right Care, Right Place, Right Time (R3) program. This model uses a preventive approach to resident services, focused on one-on-one relationship building, community-wide ...
MIAMI, FLORIDA (EMBARGOED UNTIL JAN. 9, 2024 AT 4 PM EST) – A multicenter collaboration led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has produced the first computational model for newly diagnosed multiple myeloma that predicts an individual’s personalized prognosis based on their tumor genomics and treatments.
The prediction model for individualized risk in newly diagnosed multiple myeloma, or IRMMa, improves on previous prognostic tools because it takes into account ...
“Identifying plasma proteins that regenerate aged or damaged ovaries could lead to more effective, targeted and/or preventive therapies for patients.”
BUFFALO, NY- January 9, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 24, entitled, “Systemic changes induced by autologous stem cell ovarian transplant in plasma proteome of women with impaired ovarian reserves.”
Patients with poor ...
People who own electric vehicles (EVs) are more likely to go a step further and add solar panels to their home, according to an analysis of a behavioral study by researchers at the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL). Conversely, the impact of owning solar panels also has a bearing on whether a homeowner buys an electric vehicle but not as strongly.
The study relied on a survey of 869 households in the San Francisco Bay Area.
NREL’s Shivam Sharda, lead author of the newly published research paper that analyzes the ...
University of Colorado Cancer Center member Sana Karam, MD, PhD, has received a translational research grant from the V Foundation for Cancer Research, co-founded by ESPN and legendary basketball coach Jim Valvano, to study a new therapeutic that may help pancreatic cancer patients overcome resistance to radiation therapy.
“Pancreatic cancer is deadly. The only treatment that can cure it is surgery to fully remove the tumor, but that is only an option when the cancer is caught early, which is rare,” Karam explains. “Radiation alone to shrink tumors before surgery has been tried, but with limited benefit. By studying patient ...
New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, PhD, could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene — a mutation also responsible for some types of melanoma, colorectal cancer, leukemia, lymphoma, and ovarian cancer.
“The BRAF mutation is a common mutation in thyroid cancer,” Schweppe says. “It has a high prevalence of mutations in two different subtypes — papillary thyroid cancer, or PTC, and anaplastic thyroid cancer, or ATC — and there's a lot of interest in targeting this pathway. Other tumor types, like melanoma ...
Waltham — January 8, 2024 — Proper procedures for diagnosing prolonged grief disorder (PGD) are not being followed in research into its prevalence, according to a study published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer. What’s more, most published literature doesn’t clearly acknowledge the limitations of the methodology used.
The lead investigator was Margaret S. Stroebe, PhD, a clinical psychologist at Utrecht University and the University of Groningen ...
The University of Rochester will house a new national center focused on using tissue-on-chip technology to develop drugs more rapidly and reduce the need for animal trials. The National Institutes of Health awarded a $7.5 million grant to establish the Translational Center for Barrier Microphysiological Systems (TraCe-bMPS) at Rochester in partnership with Duke University.
The center aims to develop five Food and Drug Administration–qualified drug development tools related to ...
